Bokf, Na Repligen Corp Transaction History

Bokf, Na

  • $6.09 Billion
  • Q2 2025

A detailed history of Bokf, Na transactions in Repligen Corp stock. As of the latest transaction made, Bokf, Na holds 155 shares of RGEN stock, worth $18,817. This represents 0.0% of its overall portfolio holdings.

Number of Shares
155
Previous 5 3000.0%
Holding current value
$18,817
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
BUY
$108.89 - $145.23 $16,333 - $21,784
150 Added 3000.0%
155 $19,000
Q4 2024

Feb 13, 2025
BUY
$123.41 - $160.92 $370 - $482
3 Added 150.0%
5 $0
Q1 2024

May 15, 2024
BUY
$170.78 - $208.42 $170 - $208
1 Added 100.0%
2 $0
Q3 2023

Nov 14, 2023
SELL
$138.78 - $176.51 $23,315 - $29,653
-168 Reduced 99.41%
1 $0
Q2 2023

Aug 21, 2023
SELL
$138.42 - $180.31 $11,350 - $14,785
-82 Reduced 32.67%
169 $23,000
Q1 2023

May 11, 2023
BUY
$154.26 - $198.1 $38,719 - $49,723
251 New
251 $42,000
Q2 2022

Aug 11, 2022
SELL
$140.68 - $188.02 $166,846 - $222,991
-1,186 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$161.19 - $257.96 $18,698 - $29,923
-116 Reduced 8.91%
1,186 $223,000
Q4 2021

Mar 11, 2022
SELL
$247.59 - $304.47 $3,466 - $4,262
-14 Reduced 1.06%
1,302 $345,000
Q3 2021

Nov 10, 2021
BUY
$194.77 - $324.21 $256,317 - $426,660
1,316 New
1,316 $380,000
Q1 2021

Apr 21, 2021
SELL
$180.37 - $226.26 $216,985 - $272,190
-1,203 Closed
0 $0
Q4 2020

Feb 12, 2021
SELL
$148.08 - $206.57 $36,575 - $51,022
-247 Reduced 17.03%
1,203 $231,000
Q3 2020

Oct 30, 2020
BUY
$122.51 - $158.27 $177,639 - $229,491
1,450 New
1,450 $214,000

Others Institutions Holding RGEN

# of Institutions
494
Shares Held
57.4M
Call Options Held
75.6K
Put Options Held
521K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.74B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Bokf, Na Portfolio

Follow Bokf, Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email